Viridian Therapeutics, Inc.DE（VRDN）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Viridian Therapeutics, Inc.DE（VRDN）报告了 29 笔 Form 4 交易（最近一笔 2026-08-20）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-20 | Tousignant Jennifer | Chief Legal Officer | 卖出 | 4,212 | $103,194 |
| 2026-08-20 | Tousignant Jennifer | Chief Legal Officer | 买入 | 10,000 | $144,100 |
| 2026-08-20 | Tousignant Jennifer | Chief Legal Officer | 卖出 | 10,000 | $245,000 |
| 2026-08-18 | Tripuraneni Radhika | Chief Medical Officer | 买入 | 40,000 | $528,400 |
| 2026-05-13 | Fairmount Healthcare Fund II L.P. | 董事 | 买入 | 1.2M | $20.0M |
| 2026-05-13 | Fairmount Funds Management LLC | 董事 | 买入 | 1.2M | $20.0M |
| 2026-05-13 | Fairmount Healthcare Fund II GP LLC | 董事 | 买入 | 1.2M | $20.0M |
| 2026-03-09 | Harmon Seth | Chief Financial Officer | 卖出 | 2,031 | $61,316 |
| 2026-03-09 | Mahoney Stephen F. | President and CEO | 卖出 | 7,408 | $223,648 |
| 2026-03-09 | Tousignant Jennifer | Chief Legal Officer | 卖出 | 1,675 | $50,568 |
| 2026-03-09 | Beetham Thomas W. | Chief Operating Officer | 卖出 | 3,048 | $92,019 |
| 2026-03-04 | Harmon Seth | Chief Financial Officer | 卖出 | 2,091 | $61,308 |
| 2026-03-04 | Harmon Seth | Chief Financial Officer | 买入 | 6,267 | $0 |
| 2026-03-04 | Tousignant Jennifer | Chief Legal Officer | 买入 | 5,169 | $0 |
| 2026-03-04 | Tousignant Jennifer | Chief Legal Officer | 卖出 | 1,724 | $50,548 |
| 2026-03-04 | Beetham Thomas W. | Chief Operating Officer | 买入 | 9,409 | $0 |
| 2026-03-04 | Beetham Thomas W. | Chief Operating Officer | 卖出 | 3,138 | $92,006 |
| 2026-03-04 | Mahoney Stephen F. | President and CEO | 买入 | 18,357 | $0 |
| 2026-03-04 | Mahoney Stephen F. | President and CEO | 卖出 | 7,627 | $223,624 |
| 2026-01-02 | Tousignant Jennifer | Chief Legal Officer | 卖出 | 2,272 | $70,796 |
| 2025-10-27 | Fairmount Healthcare Fund II L.P. | 董事 | 买入 | 454,545 | $10.0M |
| 2025-10-27 | Fairmount Funds Management LLC | 董事 | 买入 | 454,545 | $10.0M |
| 2025-10-27 | Fairmount Healthcare Fund II GP LLC | 董事 | 买入 | 454,545 | $10.0M |
| 2025-06-11 | Fairmount Healthcare Fund II L.P. | 董事 | 买入 | 1,600 | $12,480 |
| 2025-06-11 | Fairmount Funds Management LLC | 董事 | 买入 | 1,600 | $12,480 |
来源：SEC Form 4 申报文件 · 截至 2026-08-20